Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of various endothelial biomarkers in ankylosing spondylitis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Atherosclerosis has been shown to be increased in chronic inflammatory diseases including ankylosing spondylitis (AS). Impaired endothelial function, the first step in atherosclerosis, may be reflected by changes in various endothelial biomarkers of hemostasis and the release of several cellular adhesion molecules or cytokines. In this study, we investigated changes in the levels of various possible markers with regard to disease activity and treatment regimen with/without anti-TNF-α drugs. Fifty-six AS patients (44 males) and 27 controls (19 males) with no known cardiovascular risk factors were included in the study. Spinal mobility was assessed by the Bath Ankylosing Spondylitis Metrology Index, and patients were evaluated with the Bath Ankylosing Spondylitis Functional Index and the Bath Ankylosing Spondylitis Disease Activity Index. Cytokines and various endothelial biomarkers were measured in serum samples using commercially available ELISA kits. Age, sex, BMI, waist circumference, fasting glucose, MAP, lipids are all similar between patients and controls. von Willebrand factor (vWF), soluble thrombomodulin (sTM), and urotensin (UT-II) were found to be significantly higher in the sera of the patients compared to the controls. Treatment with anti-TNF-α compared to conventional therapy and disease activity in AS patients seemed to have no effect on the blood levels of UT-II, sTM, CD146, vWF, plasminogen activator inhibitor-1, tissue plasminogen activator, or the thrombin–antithrombin complex. The increased UT-II, sTM, and vWF in AS patient sera regardless of treatment and disease activity suggest an increased tendency for atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379–1390

    Article  PubMed  Google Scholar 

  2. Okan T, Sari I, Akar S, Cece H, Goldeli O, Guneri S et al (2008) Ventricular diastolic function of ankylosing spondylitis patients by using conventional pulsed wave Doppler, myocardial performance index and tissue Doppler imaging. Echocardiography 25(1):47–56

    PubMed  Google Scholar 

  3. Sari I, Okan T, Akar S, Cece H, Altay C, Secil M et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45(3):283–286

    Article  CAS  Google Scholar 

  4. Sari I, Kebapcilar L, Alacacioglu A, Bilgir O, Yildiz Y, Taylan A et al (2009) Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis. Intern Med 48(16):1363–1368

    Article  PubMed  Google Scholar 

  5. Sari I, Kebapcilar L, Taylan A, Bilgir O, Kozaci DL, Yildiz Y et al (2010) Fetuin-A and interleukin-18 levels in ankylosing spondylitis. Int J Rheum Dis 13(1):75–81

    Article  PubMed  Google Scholar 

  6. Jarvisalo MJ, Juonala M, Raitakari OT (2006) Assessment of inflammatory markers and endothelial function. Curr Opin Clin Nutr Metab Care 9(5):547–552

    Article  PubMed  CAS  Google Scholar 

  7. Vischer UM (2006) von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 4(6):1186–1193

    Article  PubMed  CAS  Google Scholar 

  8. Loirand G, Rolli-Derkinderen M, Pacaud P (2008) Urotensin II and atherosclerosis. Peptides 29(5):778–782

    Article  PubMed  CAS  Google Scholar 

  9. Blann AD, Pretorius A (2006) Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? Atherosclerosis 188(1):12–18

    Article  PubMed  CAS  Google Scholar 

  10. van der Linden S, Valkenburg HA (1984) Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  PubMed  Google Scholar 

  11. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694–1698

    PubMed  CAS  Google Scholar 

  12. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285

    PubMed  CAS  Google Scholar 

  13. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801–809

    Article  PubMed  CAS  Google Scholar 

  14. van Eijk IC, Peters MJ, Serne EH, van der Horst-Bruinsma IE, Dijkmans BA, Smulders YM et al (2008) Microvascular function is impaired in ankylosing spondylitis and improves after TNF{alpha} blockade. Ann Rheum Dis 68:362–366

    Article  PubMed  Google Scholar 

  15. Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R et al (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88(6):358–365

    Article  Google Scholar 

  16. Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8(4):281–286

    Article  PubMed  Google Scholar 

  17. de Groot L, Posthumus MD, Kallenberg CG, Bijl M (2010) Risk factors and early detection of atherosclerosis in rheumatoid arthritis. Eur J Clin Invest 40(9):835–842

    Article  PubMed  Google Scholar 

  18. Haskard DO (2004) Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 33(5):281–292

    Article  PubMed  CAS  Google Scholar 

  19. Bardin N, Blot-Chabaud M, Despoix N, Kebir A, Harhouri K, Arsanto JP et al (2009) CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler Thromb Vasc Biol 29(5):746–753

    Article  PubMed  CAS  Google Scholar 

  20. Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J et al (2006) Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis 12(1):16–21

    Article  PubMed  Google Scholar 

  21. Sari I, Alacacioglu A, Kebapcilar L, Taylan A, Bilgir O, Yildiz Y et al (2010) Assessment of soluble cell adhesion molecules and soluble CD40 ligand levels in ankylosing spondylitis. Joint Bone Spine 77(1):85–87

    Article  PubMed  Google Scholar 

  22. Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R (2005) Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109(2):171–176

    Article  CAS  Google Scholar 

  23. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196(2):193–222

    Article  CAS  Google Scholar 

  24. Agirbasli M, Inanc N, Baykan OA, Direskeneli H (2006) The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders. Clin Exp Rheumatol 24(5):580–583

    PubMed  CAS  Google Scholar 

  25. Diebold I, Kraicun D, Bonello S, Gorlach A (2008) The ‘PAI-1 paradox’ in vascular remodeling. Thromb Haemost 100(6):984–991

    PubMed  CAS  Google Scholar 

  26. Fay WP, Garg N, Sunkar M (2007) Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 27(6):1231–1237

    Article  PubMed  CAS  Google Scholar 

  27. Medcalf RL (2007) Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost 5(Suppl 1):132–142

    Article  PubMed  CAS  Google Scholar 

  28. Bounameaux H, Kruithof EK (2000) On the association of elevated tPA/PAI-1 complex and von Willebrand factor with recurrent myocardial infarction. Arterioscler Thromb Vasc Biol 20(8):1857–1859

    Article  PubMed  CAS  Google Scholar 

  29. Blann AD, McCollum CN (1999) von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis. Blood Coagul Fibrinolysis 10(6):375–380

    Article  PubMed  CAS  Google Scholar 

  30. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN (1997) Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 27(11):916–921

    Article  PubMed  CAS  Google Scholar 

  31. Li YH, Shi GY, Wu HL (2006) The role of thrombomodulin in atherosclerosis: from bench to bedside. Cardiovasc Hematol Agents Med Chem 4(2):183–187

    Article  PubMed  CAS  Google Scholar 

  32. Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N (1994) Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol 101(1):109–113

    PubMed  CAS  Google Scholar 

  33. Kotajima L, Aotsuka S, Sato T (1997) Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases. Clin Exp Rheumatol 15(1):59–65

    PubMed  CAS  Google Scholar 

  34. Borissoff JI, Heeneman S, Kilinc E, Kassak P, Van Oerle R, Winckers K et al (2010) Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 122(8):821–830

    Article  PubMed  CAS  Google Scholar 

  35. Haverkate F (2002) Levels of haemostatic factors, arteriosclerosis and cardiovascular disease. Vascul Pharmacol 39(3):109–112

    Article  PubMed  CAS  Google Scholar 

  36. Kemp W, Roberts S, Krum H (2005) Urotensin II: a vascular mediator in health and disease. Curr Vasc Pharmacol 3(2):159–168

    Article  PubMed  CAS  Google Scholar 

  37. Pakala R (2008) Role of urotensin II in atherosclerotic cardiovascular diseases. Cardiovasc Revasc Med 9(3):166–178

    Article  PubMed  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Department of Rheumatology, Izmir Tepecik Training and Research Hospital, Izmir, Turkey

    Ali Taylan

  2. Department of Rheumatology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey

    Ismail Sari

  3. Department of Biochemistry, Adnan Menderes University School of Medicine, Aydin, Turkey

    Didem L. Kozaci

  4. Bilim ve Teknoloji Araştırma ve Uygulama Merkezi (ADU-BILTEM), Adnan Menderes University, Aydin, Turkey

    Didem L. Kozaci & Necati Gunay

  5. Department of Internal Medicine, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey

    Yasar Yildiz

  6. Department of Physical Medicine and Rehabilitation, Izmir Tepecik Training and Research Hospital, Izmir, Turkey

    Safak Bilge

  7. Department of Biochemistry, Izmir Tepecik Training and Research Hospital, Izmir, Turkey

    Isil Coker

  8. Department of Internal Medicine, Izmir Tepecik Training and Research Hospital, Izmir, Turkey

    Sergir Maltas

  9. Division of Rheumatology, Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir, Turkey

    Nurullah Akkoc

  10. Izmir Tepecik Eğitim ve Arastirma Hastanesi, Romatoloji Bolumu, Yenişehir, Izmir, Turkey

    Ali Taylan

Authors
  1. Ali Taylan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ismail Sari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Didem L. Kozaci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasar Yildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Safak Bilge
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Isil Coker
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sergir Maltas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Necati Gunay
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nurullah Akkoc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Taylan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylan, A., Sari, I., Kozaci, D.L. et al. Evaluation of various endothelial biomarkers in ankylosing spondylitis. Clin Rheumatol 31, 23–28 (2012). https://doi.org/10.1007/s10067-011-1760-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1760-z

Keywords

Search

Navigation